Leadership Team

A novel approach to target inflammatory diseases

Jean-Jacques Garaud

MD, Cofounder and CEO

Senior executive with broad and deep experience in R&D in the pharmaceutical industry

• Head of Pharma Research and Early Development at Roche (2010 to 2012)

• Head of Development and Chief Medical Officer at Roche (2007 to 2010)

• Non-Executive Director Enyo, Lyon.

Martin Koch

COO

Senior executive with international experience in finance and operational functions.

• CFO of Genticel, a listed French biotech (2007 – 2017)

• Sales Director, Oncology Cephalon Pharma France (2006 – 2007)

• Controlling and Finance Director functions at Elan & Zeneus Pharma UK (2001 – 2005).

Dr. Marc Derive

PHD, Cofounder, CSO

PhD in immunology and a post-doctoral fellowship at the University of Lorraine, France.  MBA HEC

• Led the discovery and early development of TREM-1 inhibitor drug candidates (5 patents, several publications)

• Creation of INOTREM (2013)

Dr. Margarita Salcedo Magguilli

CDO

PhD in Immunology and Tumor Biology at the Karolinska Institute in Stockholm.

• Director of Translational Research at the Oncology R&D Unit, Servier International Research Institute

• Director Translational Medicine, LFB biotechnologies, a French biopharmaceutical laboratory on immunology, hemostasis and intensive care therapeutic areas.